Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress and Challenges in the Biology of FNDC5 and Irisin. | Endocr Rev | 2021 | 33493316 | PubTator, text mining | PubMed |
| Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma. | BMC Cancer | 2021 | 33482765 | PubTator, text mining | PubMed |
| Genome-wide association study and pathway analysis identify NTRK2 as a novel candidate gene for litter size in sheep. | PLoS One | 2021 | 33481819 | PubTator, text mining | PubMed |
| Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases. | Antioxidants (Basel) | 2021 | 33477989 | PubTator, text mining | PubMed |
| Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems. | Pharmaceutics | 2021 | 33477395 | PubTator, text mining | PubMed |
| Variable blood processing procedures contribute to plasma proteomic variability. | Clin Proteomics | 2021 | 33468058 | PubTator, text mining | PubMed |
| Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 33466191 | PubTator, text mining | PubMed |
| Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial. | Clin Transl Med | 2021 | 33463067 | PubTator, text mining | PubMed |
| Genetics of 35 blood and urine biomarkers in the UK Biobank. | Nat Genet | 2021 | 33462484 | PubTator, text mining | PubMed |
| A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy. | Eur Radiol Exp | 2021 | 33447887 | PubTator, text mining | PubMed |
| Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling. | Epigenetics Chromatin | 2021 | 33436083 | PubTator, text mining | PubMed |
| Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity. | J Nanobiotechnology | 2021 | 33422061 | PubTator, text mining | PubMed |
| Identification of Key Phospholipids That Bind and Activate Atypical PKCs. | Biomedicines | 2021 | 33419210 | PubTator, text mining | PubMed |
| The Impact of Mitochondrial Fission-Stimulated ROS Production on Pro-Apoptotic Chemotherapy. | Biology (Basel) | 2021 | 33418995 | PubTator, text mining | PubMed |
| The diversity and breadth of cancer cell fatty acid metabolism. | Cancer Metab | 2021 | 33413672 | PubTator, text mining | PubMed |
| Analytical Platforms for the Determination of Phospholipid Turnover in Breast Cancer Tissue: Role of Phospholipase Activity in Breast Cancer Development. | Metabolites | 2021 | 33406793 | PubTator, text mining | PubMed |
| Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. | Elife | 2021 | 33404012 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Structure-Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N-Acylphosphatidylethanolamine Phospholipase D. | J Med Chem | 2021 | 33382264 | PubTator, text mining | PubMed |
| PLD1 and PLD2 differentially regulate the balance of macrophage polarization in inflammation and tissue injury. | J Cell Physiol | 2021 | 33368247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=54